In this study, we hypothesized that DHM could promote GLP‐1 level and improve insulin resistance in HFD‐induced mice by modulation of gut microbiota and the metabolites, which might be associated with modulation of the intestinal L cells and certain subsets of IELs cells. The gene discussed is GCG; the disease is Insulin resistance.